ST(002872.SZ): Sodium Bicarbonate Injection Passes Generic Drug Consistency Evaluation.

date
14/09/2025
Wisdom Financial APP News, ST Tiansheng (002872.SZ) announced that its wholly-owned subsidiary Hubei Tiansheng Pharmaceutical Co., Ltd. (hereinafter referred to as "Hubei Tiansheng") recently received the "Drug Supplementary Application Approval Notice" issued by the National Medical Products Administration. Hubei Tiansheng's product "Sodium Bicarbonate Injection" has passed the evaluation of generic drug quality and efficacy consistency.